| Literature DB >> 33785047 |
Daichi Ishikawa1, Yukako Takehara2, Atsushi Takata2, Kazuhito Takamura2, Hirohiko Sato2.
Abstract
BACKGROUND: "Dirty mass" is a specific computed tomography (CT) finding that is seen frequently in colorectal perforation. The prognostic significance of this finding for mortality is unclear.Entities:
Keywords: APACHE II; Colorectal perforation; Dirty mass; Prognostic factor
Year: 2021 PMID: 33785047 PMCID: PMC8008772 DOI: 10.1186/s13017-021-00359-y
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Patient characteristics
| Factor | ( |
|---|---|
| Age (years) | 80 (36-94) |
| Male | 29 (50) |
| BMI | 21.7 ± 3.8 |
| ASA-PS | |
| I | 6 (10.3) |
| II | 28 (48.3) |
| III | 22 (37.9) |
| IV | 2 (3.4) |
| Survived/mortality | 45 (77.6)/13 (22.4) |
| Comorbidity | 38 (65.5) |
| Steroid | 6 (10.3) |
| Cause | |
| Diverticulitis | 24 (41.4) |
| Cancer | 18 (31.0) |
| Ischemia | 6 (10.3) |
| Idiopathic | 5 (8.6) |
| Other | 5 (8.6) |
| Perforation site | |
| Ascending colon | 9 (15.5) |
| Transverse colon | 7 (12.1) |
| Descending colon | 4 (6.9) |
| Sigmoid colon | 28 (48.3) |
| Rectum | 10 (17.2) |
| Length of operation (min) | 114 (54-182) |
| Blood loss (ml) | 59 (10-1500) |
Data are expressed as the median (range), mean ± standard deviation, or n (%)
BMI body mass index, ASA-PS American Society of Anesthesiologists-Physical Status
Comparison of patient background, physical examination, and disease factors between the survivor and mortality groups
| Survivors | Mortality | ||
|---|---|---|---|
| ( | ( | ||
| Age (years) | 79 (36-94) | 82 (68-90) | 0.042* |
| Male | 23 | 6 | 1.000 |
| BMI (kg/m2) | 21.9 ± 4.0 | 21.1 ± 2.4 | 0.632 |
| ASA-PS | |||
| I | 6 | 0 | |
| II | 25 | 3 | |
| III | 13 | 9 | |
| IV | 1 | 1 | 0.028* |
| Comorbidity | 26 | 12 | 0.048* |
| Steroid use | 4 | 2 | 0.873 |
| Heart rate (/min) | 94 (56-134) | 100 (54-143) | 0.081 |
| MAP (mmHg) | 88 ± 17 | 75 ± 20 | 0.023* |
| Body temperature (°C) | 37.3 (35.0-39.8) | 36.9 (35.5-38.5) | 0.102 |
| Time from onset to surgery (h) | |||
| >24 h | 18 | 2 | 0.189 |
| Cause | |||
| Diverticulitis | 3 | 21 | |
| Cancer | 6 | 12 | |
| Idiopathic | 0 | 5 | |
| Ischemia | 2 | 4 | |
| Other | 2 | 3 | 0.255 |
| Perforation site | |||
| Ascending colon | 6 | 3 | |
| Transverse colon | 6 | 1 | |
| Descending colon | 3 | 1 | |
| Sigmoid colon | 22 | 6 | |
| Rectum | 8 | 2 | 0.922 |
Data are expressed as the median (range), mean ± standard deviation
Comorbidities include diabetes mellitus, heart, lung, or renal disease
BMI body mass index, ASA-PS American Society of Anesthesiologists-Physical Status, MAP mean arterial pressure
*p < 0.05
Comparison of therapeutic factors, examination data, and score values between the survivor and mortality groups
| Survivors | Mortality | ||
|---|---|---|---|
| ( | ( | ||
| Procedure | |||
| Hartmann’s procedure | 30 | 12 | |
| Colectomy and PA | 11 | 1 | |
| Stoma creation | 4 | 0 | 0.179 |
| Length of operation | 118 (54-182) | 106 (72-152) | 0.837 |
| Blood loss | 60 (10-1500) | 59 (10-324) | 0.747 |
| Transfusion | 20 | 5 | 0.948 |
| Ventilator use | 16 | 10 | 0.020* |
| PMX-DHP use | 15 | 7 | 0.309 |
| IVIG use | 12 | 7 | 0.133 |
| Thrombomodulin use | 18 | 10 | 0.042* |
| Hemoglobin (g/dl) | 12.1 ± 2.5 | 12.5 ± 2.8 | 0.608 |
| WBC (/μl) | 8660 (660-27940) | 6100 (1240-15940) | 0.531 |
| Platelet (×103/μl) | 249 ± 120 | 219 ± 100 | 0.439 |
| CRP (mg/dl) | 12.3 ±11.8 | 6.4 ± 8.3 | 0.156 |
| Albumin (mg/dl) | 3.3 ± 0.7 | 3.0 ± 0.6 | 0.167 |
| Creatinine (mg/dl) | 1.5 ± 1.6 | 2.4 ± 2.2 | 0.060 |
| Dirty mass volume (cm3) | 54 ± 100 | 234 ± 211 | 0.004** |
| DIC score | 1 (0-6) | 3 (0-8) | 0.007** |
| APACHE II score | 11 (3-22) | 18 (8-30) | 0.001** |
| SOFA score | 2 (0-6) | 5 (0-12) | 0.002** |
| POSSUM score | 44 (29-64) | 53 (34-74) | 0.030* |
Data are expressed as the median (range), mean ± standard deviation
PA primary anastomosis, PMX-DHP polymyxin B-immobilized fiber direct hemoperfusion, IVIG intravenous immunoglobulin, WBC white blood cells, CRP C-reactive protein, DIC disseminated intravascular coagulation, APACHE II acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, POSSUM physiological and operative severity score for the enumeration of mortality and morbidity
*p < 0.05, **p < 0.01
Fig. 13D reconstruction and quantification of dirty mass with the Ziostation software. a The position of a dirty mass is indicated by the yellow-dashed line that was hand-traced on an axial MDCT image. These outlines were used to construct a 3D image. b Representative 3D image of a dirty mass constructed using Ziostation. The dirty mass (green) is located next to the sigmoid colon (pink). The volume of the dirty mass was calculated as 419.2 cm3
Fig. 2Comparison of dirty mass volume between the survivor and mortality groups. a Dirty mass volume was significantly larger in the mortality group than the survivor group. b ROC curve showed the highest peak at dirty mass volume of 96.3cm3, with 0.643 sensitivity and 0.864 specificity
Multivariate analysis of factors prognostic for colorectal perforation
| Odds ratio | ||
|---|---|---|
| Dirty mass volume | 1.010 (1.000-1.020) | 0.006** |
| DIC score | 1.310 (0.678-2.520) | 0.424 |
| APACHE II score | 1.400 (1.070-1.850) | 0.015* |
| SOFA score | 1.170 (0.699-1.950) | 0.554 |
Values in parentheses are the 95% confidence interval
DIC disseminated intravascular coagulation, APACHE II acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, POSSUM physiological and operative severity score for the enumeration of mortality and morbidity
*p < 0.05, **p < 0.01
Fig. 3Stratification of mortality risk according to dirty mass volume and APACHE II score. Patients with colorectal perforation were divided into four groups (A to D) according to various combinations of dirty mass volume and APACHE II score. The mortality rates for groups A, B, C, and D were 42.8%, 66.6%, 0%, and 20.0%, respectively